{"id":"https://openalex.org/W2955440919","doi":"https://doi.org/10.1158/1538-7445.sabcs18-924","title":"Abstract 924: The androgen receptor antagonist darolutamide shows strong antitumor efficacy in patient- and cell line-derived xenograft prostate cancer models","display_name":"Abstract 924: The androgen receptor antagonist darolutamide shows strong antitumor efficacy in patient- and cell line-derived xenograft prostate cancer models","publication_year":2019,"publication_date":"2019-07-01","ids":{"openalex":"https://openalex.org/W2955440919","doi":"https://doi.org/10.1158/1538-7445.sabcs18-924","mag":"2955440919"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.sabcs18-924","doi":"https://doi.org/10.1158/1538-7445.sabcs18-924","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.sabcs18-924","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Endocrinology","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5046614767","display_name":"Pascale Lejeune","orcid":"https://orcid.org/0000-0002-0665-5783","observed_orcids":["https://orcid.org/0000-0002-0665-5783"]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Pascale Lejeune","raw_affiliation_strings":["Bayer AG, Berlin, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer AG, Berlin, Germany","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064749364","display_name":"Antje Margret Wengner","orcid":"https://orcid.org/0009-0009-5772-1945","observed_orcids":["https://orcid.org/0009-0009-5772-1945"]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Antje Wengner","raw_affiliation_strings":["Bayer AG, Berlin, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer AG, Berlin, Germany","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110342119","display_name":"Simon J. Baumgart","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Simon J. Baumgart","raw_affiliation_strings":["Bayer AG, Berlin, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer AG, Berlin, Germany","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029670475","display_name":"Ekaterina Nevedomskaya","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Ekaterina Nevedomskaya","raw_affiliation_strings":["Bayer AG, Berlin, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer AG, Berlin, Germany","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018745405","display_name":"Eva Corey","orcid":"https://orcid.org/0000-0002-9244-3807","observed_orcids":["https://orcid.org/0000-0002-9244-3807"]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eva Corey","raw_affiliation_strings":["University of Washington, Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Washington, Seattle, WA","institution_ids":["https://openalex.org/I201448701"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009359386","display_name":"Dominik Mumberg","orcid":"https://orcid.org/0000-0002-6670-1497","observed_orcids":["https://orcid.org/0000-0002-6670-1497"]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Dominik Mumberg","raw_affiliation_strings":["Bayer AG, Berlin, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer AG, Berlin, Germany","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5048300451","display_name":"Bernard Haendler","orcid":"https://orcid.org/0000-0002-4490-0663","observed_orcids":["https://orcid.org/0000-0002-4490-0663"]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Bernard Haendler","raw_affiliation_strings":["Bayer AG, Berlin, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer AG, Berlin, Germany","institution_ids":["https://openalex.org/I67348948"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"924","last_page":"924"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10124","display_name":"Prostate Cancer Diagnosis and Treatment","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2748","display_name":"Urology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12820","display_name":"Chromatin Remodeling and Cancer","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/darolutamide","display_name":"darolutamide","score":0.9980000257492065},{"id":"https://openalex.org/keywords/androgen-receptor-antagonists","display_name":"androgen receptor antagonists","score":0.9649999737739563},{"id":"https://openalex.org/keywords/prostate-cancer","display_name":"prostate cancer","score":0.9959999918937683},{"id":"https://openalex.org/keywords/patient-derived-xenografts","display_name":"patient-derived xenografts","score":0.9229999780654907},{"id":"https://openalex.org/keywords/cell-line-derived-xenografts","display_name":"cell line-derived xenografts","score":0.8960000276565552},{"id":"https://openalex.org/keywords/atr-inhibitors","display_name":"ATR inhibitors","score":0.9860000014305115},{"id":"https://openalex.org/keywords/combined-radiotherapy","display_name":"combined radiotherapy","score":0.5649999976158142},{"id":"https://openalex.org/keywords/dna-repair-genes","display_name":"DNA repair genes","score":0.7179999947547913},{"id":"https://openalex.org/keywords/dna-double-strand-breaks","display_name":"DNA double-strand breaks","score":0.6209999918937683},{"id":"https://openalex.org/keywords/gamma-h2ax","display_name":"\u03b3H2AX","score":0.7459999918937683},{"id":"https://openalex.org/keywords/parp-1","display_name":"PARP1","score":0.37599998712539673},{"id":"https://openalex.org/keywords/parp2","display_name":"PARP2","score":0.5870000123977661},{"id":"https://openalex.org/keywords/parp3","display_name":"PARP3","score":0.5040000081062317},{"id":"https://openalex.org/keywords/parp4","display_name":"PARP4","score":0.4560000002384186}],"concepts":[{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.7910418510437012},{"id":"https://openalex.org/C61367390","wikidata":"https://www.wikidata.org/wiki/Q416601","display_name":"Androgen receptor","level":4,"score":0.6585650444030762},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6383230686187744},{"id":"https://openalex.org/C2776235491","wikidata":"https://www.wikidata.org/wiki/Q9625","display_name":"Prostate","level":3,"score":0.5241140127182007},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5050397515296936},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4917581379413605},{"id":"https://openalex.org/C2777911890","wikidata":"https://www.wikidata.org/wiki/Q62614","display_name":"Androgen","level":3,"score":0.47316059470176697},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.4634558856487274},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.3806573152542114},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.35086047649383545},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.31120502948760986},{"id":"https://openalex.org/C71315377","wikidata":"https://www.wikidata.org/wiki/Q11364","display_name":"Hormone","level":2,"score":0.232697993516922}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.sabcs18-924","doi":"https://doi.org/10.1158/1538-7445.sabcs18-924","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.sabcs18-924","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Endocrinology","raw_type":"proceedings-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9922999739646912,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2891971316","https://openalex.org/W2918963306","https://openalex.org/W2886934564","https://openalex.org/W3083107529","https://openalex.org/W3164081628","https://openalex.org/W2883863494","https://openalex.org/W4282936667","https://openalex.org/W2746932121","https://openalex.org/W4403108645","https://openalex.org/W3017681208"],"abstract_inverted_index":{"Darolutamide":[0,40,218],"is":[1],"a":[2,13,70,110,312,422],"structurally":[3],"unique":[4],"androgen":[5,290,449],"receptor":[6,450],"(AR)":[7],"antagonist":[8,451],"which":[9,310],"has":[10],"recently":[11],"completed":[12],"pivotal":[14],"clinical":[15],"phase":[16],"3":[17,131],"trial.":[18],"Here":[19],"we":[20,300],"explored":[21],"the":[22,35,44,78,87,163,224,236,258,316,321,401,470],"efficacy":[23,231,251,456],"of":[24,74,97,114,155,199,275,283,315,323,346,370,405,416,469],"darolutamide":[25,67,107,180,242,256,355,378,417,452],"in":[26,32,43,223,235,320,341,381,383,392,418,426,457],"different":[27],"prostate":[28,175,419,463],"cancer":[29,176,420,464],"models":[30,385,465],"and":[31,48,151,184,193,277,291,389,396,459],"combination":[33,342,352,393,427],"with":[34,54,64,104,179,241,246,257,266,298,336,343,394,400,428],"ATR":[36,119,259,398],"inhibitor":[37,120,260],"BAY":[38,121,182,261,267,337],"1895344.":[39],"was":[41,80,92,123,141,159,169,232,252,287,348],"tested":[42,93],"patient-derived":[45],"xenografts":[46],"LuCaP35":[47],"LuCaP96.":[49],"The":[50,118,448],"studies":[51],"were":[52,203,212,332],"performed":[53,142,170],"SCID":[55,98],"male":[56,99],"mice":[57],"implanted":[58],"subcutaneously.":[59],"Oral,":[60,101],"twice":[61,128],"daily":[62,102,129],"treatment":[63,103,240,335,356],"100":[65,105],"mg/kg":[66,106],"started":[68,108],"at":[69,109,125,143],"mean":[71,111],"tumor":[72,112],"size":[73,113],"about":[75,115],"150":[76],"mm3;":[77],"study":[79],"stopped":[81],"3.5":[82],"weeks":[83],"later.":[84],"In":[85,296,376],"addition":[86],"cell":[88,201,460],"line-derived":[89,461],"xenograft":[90,384,462],"LAPC-4":[91,237,276],"after":[94,153,334],"subcutaneous":[95],"inoculation":[96],"mice.":[100],"50":[116],"mm2.":[117],"1895344":[122,262,268,338],"applied":[124],"20":[126],"mg/kg,":[127],"for":[130,205,473],"days":[132,136,149],"followed":[133],"by":[134,161,214,289,294],"4":[135],"without":[137],"treatment.":[138,157,353],"X-ray":[139],"radiation":[140,247,270,395],"5":[144],"Gy,":[145],"once":[146],"weekly":[147],"on":[148,171,363],"26":[150],"33":[152],"start":[154],"compound":[156],"Efficacy":[158],"evaluated":[160,213],"calculating":[162],"\u0394T/\u0394C":[164],"values.":[165],"Gene":[166],"expression":[167,282,369],"analysis":[168,274],"RNA":[172],"extracted":[173],"from":[174],"cells":[177,279],"treated":[178],"and/or":[181],"1895344,":[183],"analyzed":[185],"using":[186],"RT2":[187],"Profiler":[188],"PCR":[189],"arrays":[190],"(Qiagen).":[191],"RNA-seq":[192],"AR":[194,303,317],"ChIP-seq":[195],"(06-680,":[196],"Millipore)":[197],"datasets":[198],"darolutamide-treated":[200],"lines":[202],"used":[204],"genome-wide":[206],"studies.":[207],"\u03b3H2AX":[208,330],"(ab2893,":[209],"abcam)":[210],"levels":[211,331],"Western":[215],"blot":[216],"analysis.":[217],"showed":[219,280],"strong":[220,380,454],"anti-tumor":[221,230,414,430],"activity":[222,391,415],"LuCaP96":[225],"model":[226,238],"(6%":[227],"\u0394T/\u0394C).":[228,249,272],"Significant":[229],"also":[233,327,349],"observed":[234,253,301],"following":[239,351],"(36%":[243],"\u0394T/\u0394C)":[244,264],"or":[245,265,340,425],"(19%":[248],"Stronger":[250],"when":[254],"combining":[255],"(17%":[263],"plus":[269],"(1%":[271],"RNAseq":[273],"VCaP":[278],"that":[281,329],"DNA":[284,307,372,406],"repair":[285,308,407],"genes":[286],"regulated":[288],"efficiently":[292],"blocked":[293],"darolutamide.":[295,344],"line":[297],"this,":[299],"androgen-dependent":[302],"binding":[304],"close":[305],"to":[306],"genes,":[309],"supports":[311],"regulatory":[313],"role":[314],"signalling":[318],"pathway":[319],"regulation":[322],"these":[324,410],"genes.":[325,375,408],"We":[326],"found":[328],"increased":[333,350],"alone":[339,357],"Expression":[345],"H2AX":[347,364],"Notably,":[354],"did":[358],"not":[359],"have":[360],"comparable":[361],"effects":[362],"but":[365],"strongly":[366],"reduced":[367],"androgen-driven":[368],"several":[371],"damage":[373],"response":[374],"conclusion,":[377],"demonstrated":[379],"vivoefficacy":[382],"as":[386,421],"single":[387,423],"agent,":[388],"enhanced":[390],"an":[397],"inhibitor,":[399],"latter":[402],"involving":[403],"down-regulation":[404],"Together":[409],"results":[411],"suggest":[412],"broad":[413],"agent":[424],"other":[429],"modalities.Citation":[431],"Format:":[432],"Pascale":[433],"Lejeune,":[434],"Antje":[435],"Wengner,":[436],"Simon":[437],"J.":[438],"Baumgart,":[439],"Ekaterina":[440],"Nevedomskaya,":[441],"Eva":[442],"Corey,":[443],"Dominik":[444],"Mumberg,":[445],"Bernard":[446],"Haendler.":[447],"shows":[453],"antitumor":[455],"patient-":[458],"[abstract].":[466],"In:":[467],"Proceedings":[468],"American":[471],"Association":[472],"Cancer":[474,488],"Research":[475],"Annual":[476],"Meeting":[477],"2019;":[478],"2019":[479],"Mar":[480],"29-Apr":[481],"3;":[482],"Atlanta,":[483],"GA.":[484],"Philadelphia":[485],"(PA):":[486],"AACR;":[487],"Res":[489],"2019;79(13":[490],"Suppl):Abstract":[491],"nr":[492],"924.":[493]},"counts_by_year":[],"updated_date":"2026-10-30T12:39:25.321706","created_date":"2019-07-12T00:00:00"}